Senzime AB (Sweden) Today
| SEZI Stock | SEK 5.50 0.27 5.16% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Senzime AB is selling for under 5.50 as of the 17th of March 2025; that is 5.16 percent increase since the beginning of the trading day. The stock's last reported lowest price was 5.18. Senzime AB has about a 42 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Senzime AB develops patient-oriented monitoring systems that assess patients biochemical and physiological processes before, during and after surgery in Sweden. Senzime AB was founded in 1997 and is based in Uppsala, Sweden. Senzime AB is traded on Stockholm Stock Exchange in Sweden.. The company has 69.88 M outstanding shares. More on Senzime AB
Moving against Senzime Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Senzime Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Senzime AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Senzime AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Senzime AB (SEZI) is traded on Stockholm Exchange in Sweden and employs 18 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 531.12 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Senzime AB's market, we take the total number of its shares issued and multiply it by Senzime AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Senzime AB operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 69.88 M outstanding shares.
Senzime AB has accumulated about 74.87 M in cash with (81.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.42.
Check Senzime AB Probability Of Bankruptcy
Ownership AllocationSenzime AB shows a total of 69.88 Million outstanding shares. Senzime AB maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Senzime Ownership Details
Senzime AB Risk Profiles
Although Senzime AB's alpha and beta are two of the key measurements used to evaluate Senzime AB's performance over the market, the standard measures of volatility play an important role as well.
Senzime Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Senzime AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Senzime AB Corporate Management
Elected by the shareholders, the Senzime AB's board of directors comprises two types of representatives: Senzime AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Senzime. The board's role is to monitor Senzime AB's management team and ensure that shareholders' interests are well served. Senzime AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Senzime AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anders Selin | VP Sales | Profile | |
| Johanna Tulkki | COO CTO | Profile | |
| Rianne Waninge | Application Scientist | Profile | |
| Pia Renaudin | Chief Officer | Profile | |
| Anders Jacobson | Chief Technical Officer | Profile | |
| Slavoljub Grujicic | Chief Officer | Profile |
Additional Tools for Senzime Stock Analysis
When running Senzime AB's price analysis, check to measure Senzime AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senzime AB is operating at the current time. Most of Senzime AB's value examination focuses on studying past and present price action to predict the probability of Senzime AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senzime AB's price. Additionally, you may evaluate how the addition of Senzime AB to your portfolios can decrease your overall portfolio volatility.